NYSE:AGL - agilon health Stock Price Target and Predictions

Target and Analyst Ratings
Price Target History
Upgrades and Downgrades
About
FAQ

Consensus Rating: Buy
Consensus Price Target: $41.38
Forecasted Upside: -0.97 %
Number of Analysts: 9
Breakdown:
0 Sell Ratings
0 Hold Ratings
9 Buy Ratings
0 Strong Buy Ratings

^$41.78 As of 06/23/2021 01:00 AM ET

▼ -0.2 (-0.48%)

1 month | 3 months | 12 months

Get New agilon health Analyst Ratings Delivered To Your Inbox

Sign-up to receive the latest news and ratings for AGL and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for AGL

^$41.38

▼ -0.97% Downside Potential

This price target is based on 9 analysts offering 12 month price targets for agilon health in the last 3 months. The average price target is $41.38, with a high forecast of $45.00 and a low forecast of $37.00. The average price target represents a -0.97% upside from the last price of $41.78.

Current Consensus is Buy

The current consensus among 9 contributing investment analysts is to buy stock in agilon health.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations Description Skip Past Price Target Consensus Chart

0 strong buy ratings
0 buy ratings
0 hold ratings
0 sell ratings

Ratings as of

12/30/2019

0 strong buy ratings
0 buy ratings
0 hold ratings
0 sell ratings

Ratings as of

3/29/2020

0 strong buy ratings
0 buy ratings
0 hold ratings
0 sell ratings

Ratings as of

6/27/2020

0 strong buy ratings
0 buy ratings
0 hold ratings
0 sell ratings

Ratings as of

9/25/2020

0 strong buy ratings
0 buy ratings
0 hold ratings
0 sell ratings

Ratings as of

12/24/2020

0 strong buy ratings
0 buy ratings
0 hold ratings
0 sell ratings

Ratings as of

3/24/2021

0 strong buy ratings
9 buy ratings
0 hold ratings
0 sell ratings

Ratings as of

5/23/2021

0 strong buy ratings
9 buy ratings
0 hold ratings
0 sell ratings

Ratings as of

6/22/2021

Latest Recommendations

Show Most Recent Rating from Each Ratings Firm Show All Ratings

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
6/3/2021	Wells Fargo & Company	Boost Price Target	Overweight	$38.00 ➝ $44.00	Medium
5/28/2021	Deutsche Bank Aktiengesellschaft	Boost Price Target	Buy	$42.00 ➝ $45.00	Medium
5/10/2021	William Blair	Initiated Coverage	Outperform		Medium
5/10/2021	Wolfe Research	Initiated Coverage	Outperform	$37.00	Low
5/10/2021	Truist Securities	Initiated Coverage	Buy	$40.00	Medium
5/10/2021	JPMorgan Chase & Co.	Initiated Coverage	Overweight	$42.00	Low
5/10/2021	Deutsche Bank Aktiengesellschaft	Initiated Coverage	Buy	$42.00	Low
5/10/2021	Bank of America	Initiated Coverage	Buy	$41.00	Low
5/10/2021	The Goldman Sachs Group	Initiated Coverage	Buy	$42.00	Low
5/10/2021	Truist	Initiated Coverage	Buy	$40.00	Low
5/10/2021	Wells Fargo & Company	Initiated Coverage	Overweight	$38.00	Low

(Data available from 6/23/2016 forward)

agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. The company was founded in 2016 and is based in Long Beach, California.

Today's Range

Now: $41.78

$41.45

$42.55

50 Day Range

MA: $34.37

$29.14

$43.25

52 Week Range

Now: $41.78

$26.50

$44.83

Volume

822,632 shs

Average Volume

864,780 shs

Market Capitalization

$16.33 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of agilon health?

The following Wall Street research analysts have issued reports on agilon health in the last twelve months: Bank of America Co., Deutsche Bank Aktiengesellschaft, JPMorgan Chase & Co., The Goldman Sachs Group, Inc., Truist, Truist Securities, Wells Fargo & Company, William Blair, and Wolfe Research.
View the latest analyst ratings for AGL.

What is the current price target for agilon health?

8 Wall Street analysts have set twelve-month price targets for agilon health in the last year. Their average twelve-month price target is $41.38, suggesting a possible downside of 1.7%. Deutsche Bank Aktiengesellschaft has the highest price target set, predicting AGL will reach $45.00 in the next twelve months. Wolfe Research has the lowest price target set, forecasting a price of $37.00 for agilon health in the next year.
View the latest price targets for AGL.

What is the current consensus analyst rating for agilon health?

agilon health currently has 9 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe AGL will outperform the market and that investors should add to their positions of agilon health.
View the latest ratings for AGL.

What other companies compete with agilon health?

Other companies that are similar to agilon health include Fresenius Medical Care AG & Co. KGaA, DaVita, Sotera Health, Progyny, Tivity Health, Ontrak, SOC Telemed, HemaCare, Viemed Healthcare, Viemed Healthcare, Greenbrook TMS, Caladrius Biosciences, Cryo-Cell International, Baudax Bio and Pacific Health Care Organization.

How do I contact agilon health's investor relations team?

The company's listed phone number is 562-256-3800 and its investor relations email address is [email protected] The official website for agilon health is agilonhealth.com.